logo
Hepatitis C virus replicons
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users
HCV RNA in peripheral blood cell subsets in HCV–HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse
Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin
Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B
A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection
How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore
Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia